- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Interleukin 1 Receptor Antagonist Protein
Total 13130 results
-
Bristol-Myers SquibbSanofiCompletedAtrial FibrillationSpain
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyocardial Ischemia | Hypertrophic Cardiomyopathy | Left Ventricular HypertrophyUnited States
-
SanofiCompletedHypertension | Diabetes Mellitus Type 2Turkey
-
Merck Sharp & Dohme LLCCompleted
-
Hackensack Meridian HealthRecruitingUrinary RetentionUnited States
-
Tracon Pharmaceuticals Inc.Janssen Pharmaceutica N.V., BelgiumCompletedMetastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, ProstateUnited States
-
NYU Langone HealthWithdrawnArthrofibrosisUnited States
-
NovartisCompletedHypertension | Congestive Heart Failure
-
University of Southern DenmarkBristol-Myers SquibbCompleted
-
ANRS, Emerging Infectious DiseasesSanofiCompletedHepatitis C, ChronicFrance
-
Boehringer IngelheimCompletedHypertension | Diabetic NephropathiesSpain, Taiwan, Malaysia, Italy, Portugal, France, Czech Republic, Korea, Republic of, Russian Federation, Denmark, Germany, Slovakia, Ukraine
-
NovartisCompleted
-
Slovak Academy of SciencesUnknown
-
AstraZenecaCompleted
-
TakedaCompletedHypertensionUnited States, Puerto Rico
-
AstraZenecaTakedaCompletedObservational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France (SISTOLA)Heart Failure | Cohort StudyFrance
-
TakedaCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular DiseaseUnited States
-
Stanford UniversityActive, not recruiting
-
Centro Cardiologico MonzinoCompletedChronic Heart FailureItaly
-
GlaxoSmithKlineCompletedCardiovascular DiseaseIndia
-
EMD SeronoTerminatedArthritis, PsoriaticUnited States, Canada
-
NYU Langone HealthNot yet recruitingArthrofibrosis of KneeUnited States
-
University of Kansas Medical CenterCompleted
-
Seoul National University HospitalMinistry of Food and Drug Safety, KoreaCompletedGlomerulonephritis, IGAKorea, Republic of
-
Johns Hopkins UniversityNational Institutes of Health (NIH); National Institute on Aging (NIA)Completed
-
Academisch Medisch Centrum - Universiteit van Amsterdam...The Interuniversity Cardiology Institute of the NetherlandsUnknownHeart Defects, Congenital | Tetralogy of Fallot | Ventricular Dysfunction, RightNetherlands
-
Melbourne HealthCompletedRenal Failure | Left Ventricular HypertrophyAustralia
-
Kaiser PermanenteUniversity of California, DavisWithdrawnHepatitis CUnited States
-
SanofiBristol-Myers SquibbCompleted
-
Charite University, Berlin, GermanyUniversity of UlmCompletedCoronary Artery Disease | Hypertension | Type 2 Diabetes MellitusGermany
-
Cytheris SACytheris, Inc.TerminatedKidney Cancer | Melanoma (Skin)United States
-
Chinese Medical AssociationNot yet recruitingSeptic Shock | Tachycardia
-
NovartisCompletedHypertensionSwitzerland, Germany
-
NovartisCompletedHypertensionGermany, Switzerland
-
GlaxoSmithKlinePPDWithdrawn
-
NIZO Food ResearchFrieslandCampinaCompleted
-
Josep M CruzadoRecruitingChronic Kidney Allograft NephropathySpain
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityThird Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingHypertension,Nephropathy
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)TerminatedHypertension | Proteinuria | Sickle Cell Disease | Anemia, Sickle Cell | Kidney DiseaseUnited States
-
Boryung Pharmaceutical Co., LtdAsan Medical Center; Ulsan University Hospital; Korea University Anam Hospital; Dong-A University and other collaboratorsCompleted
-
Korea University Anam HospitalCompletedCoronary Artery Disease | Hypertension | DiabetesKorea, Republic of
-
TakedaTerminatedHypertension | DiabetesUnited States
-
Boehringer IngelheimCompleted
-
Nara Medical UniversityCompleted
-
Ligand PharmaceuticalsCompletedHypertensionUnited States
-
BayerCompletedHypertensionPoland, Slovakia, Croatia, Slovenia
-
Shanghai Jiao Tong University School of MedicineCompletedDiabetic Nephropathy | Type 2 Diabetes | Obese | Glucose Metabolism | Angiotensin II Type 1 Receptor Blockers